OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-DFFA antibodies

Anti-DFFA Antibody

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA312945
  • Rabbit polyclonal DFF45 (Cleaved-Asp224) antibody
100ul $325 In Stock

Buy any antibody of 100ul or more, get a free package of 3 loading control antibody samples. View Details Add to Shopping Cart

spacer
IHC(1)

OriGene Data

ImmunogenThe antiserum was produced against synthesized peptide derived from human DFF45.
Clone Name IsotypeIgG
Species ReactivityHuman Concentration1mg/ml
Guaranteed Application *IHC Suggested DilutionsIHC: 1:50~100, ELISA: 1:5000
BufferPhosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Note DFF45 (Cleaved-Asp224) antibody detects endogenous levels of fragment of activated DFF45 resulting from cleavage adjacent to Asp224.

Reference Data

Target NameHomo sapiens DNA fragmentation factor, 45kDa, alpha polypeptide (DFFA), transcript variant 1
Alternative NameDFF-45; DFF1; ICAD
Database LinkNP_004392
Entrez Gene 1676 Human
Function
Related Pathway Apoptosis

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

Immunohistochemical analysis of paraffin-embedded human lung carcinoma tissue, using DFF45 (Cleaved-Asp224) antibody.The picture on the right is treated with the synthesized peptide.
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title